-+ 0.00%
-+ 0.00%
-+ 0.00%

Rosenblatt Maintains Buy on Imax, Maintains $35 Price Target

Benzinga·07/11/2025 11:13:57
Listen to the news
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and maintains $35 price target.